Abstract
Menkes disease, also known as kinky hair disease (OMIM 309400), is a lethal X-linked recessive neurodegenerative disease of impaired copper transport. Menkes first described the disease in 1962, followed by Danks’ keen observation in 1973. The incidence of Menkes disease in Europe is approximately 1 in 300,000 live births, caused by mutations in the Xq13.3 gene ATP7A. Clinical symptoms, in addition to pili torti (kinky hair), begin at 2–3 months of age with loss of developmental milestones, truncal hypotonia, seizures, urologic problems, recurrent infections, and failure to thrive. Milder variants of Menkes disease include the occipital horn syndrome (also known as X-linked cutis laxa or Ehlers-Danlos type 9). The clinical characteristics, pathophysiology, diagnosis, and management options are reviewed in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Patel P, Prabhu AV, Thomas G. Benedek TG. The history of John Hans Menkes and kinky hair syndrome. JAMA Dermatol 2017; 153: 54.
Tümer Z, Møller LB. Menkes disease. Eur J Hum Genet. 2010;18:511–8.
Vairo FPE, Chwal BC, Perini S, et al. A systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease. JAM Mol Genet Metab. 2019;126:6–13.
Jones C, Daly N, Cobine P, et al. Structure and metal binding studies of the second copper binding domain of the Menke’s ATPase. J Structural Biol. 2003;143:209–18.
Danks DM, Cartwright E, Stevens BJ. Menkes’ steely-hair (kinky-hair) disease. Lancet. 1973;21:891.
De Bie P, Muller P, Wijmenga C, Klomp LW. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet. 2007;44:673–88.
Møller LB, Tümer Z, Lund C. Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome. Am J Hum Genet. 2000;66:1211–20.
Petris MJ, Mercer JF. The Menkes protein (ATP7A; MNK) cycles via the plasma membrane both in basal and elevated extracellular copper using a C-terminal di-leucine endocytic signal. Hum Mol Genet. 1999;8:2107–15.
Tümer Z, Møller LB, Horn N. Mutation spectrum of ATP7A, the gene defective in Menkes disease. Adv Exp Med Biol. 1999;448:83–95.
Kodama H, Murata Y. Molecular genetics and pathophysiology of Menkes disease. Pediatr Int. 1999;41:430–5.
Kodama H, Murata Y, Kobayashi M. Clinical manifestations and treatment of Menkes disease and its variants. Pediatr Int. 1999;41:423–9.
Smpokou P, Samanta M, Berry GT, et al. Menkes disease in affected females: the clinical disease spectrum. Am J Med Genet A. 2015;167A:417–20.
Hart DB. Menkes syndrome: an updated review. J Amer Academy Dermatol. 1983;9:145–52.
Tümer Z, Horn N. Menkes disease: recent advances and new aspects. J Med Genetics. 1997;34:265–74.
Ferreira RC, Heckenlively JR, Menkes JH. Menkes disease. New ocular and electroretinographic findings. Ophthalmology. 1998;105:1076–8.
Gasch AT, Kaler SG, Kaiser-Kupfer M. Menkes disease [letter; comment]. Ophthalmology. 1999;106:442–3.
Bahi-Buisson N, Kaminska A, Nabbout R, et al. Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia. 2006;47:380–6.
Verrotti A, Cusmal R, Darra F, et al. Epilepsy in Menkes disease: an electroclinical long-term study of 28 patients. Epilepsy Res. 2014;108:1597–603.
Kim MY, Kim JH, Cho MH, et al. Urological problems in patients with Menkes disease. J Korean Med Sci. 2018;34:e4.
Waggoner DJ, Bartnikas TB, Gitlin JD. The role of copper in neurodegenerative disease. Neurobiol Dis. 1999;6:221–30.
Schlief ML, Gitlin JD. Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus. Mol Neurobiol. 2006;33:81–90.
Aoki T, ALIA. Wilson's disease and Menkes disease. Pediatr Int. 1999;41:403–4.
Goodyer ID, Jones EE, Monaco AP. Characterization of the Menkes protein copper-binding domains and their role in copper-induced protein relocalization. Hum Mol Genet. 1999;8:1473–8.
Menkes JH. Menkes disease and Wilson disease: two sides of the same copper coin. Part I: Menkes disease. Eur J Paediatr Neurol. 1999;3:147–58.
Martinelli D, Travaglini L, Drouin CA, et al. MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapy. Brain. 2013;136:872–81.
Ambrosini L, Mercer JF. Defective copper-induced trafficking and localization of the Menkes protein in patients with mild and copper-treated classical Menkes disease. Hum Mol Genet. 1999;8:1547–55.
Kaler SG. Metabolic and molecular bases of Menkes disease and occipital horn syndrome. Pediatr Dev Pathol. 1998;1:85–98.
Mercer JF, Ambrosini L, Horton S. Animal models of Menkes disease. Adv Exp Med Biol. 1999;448:97–108.
Pedespan JM, Jouaville LS, Cances C. Menkes disease: study of the mitochondrial respiratory chain in three cases. Eur J Paediatr Neurol. 1999;3:167–70.
Petris MJ, Mercer JF, Camakaris J. The cell biology of the Menkes disease protein. Adv Exp Med Biol. 1999;448:53–66.
Suzuki M, Gitlin JD. Intracellular localization of the Menkes and Wilson’s disease proteins and their role in intracellular copper transport. Pediatr Int. 1999;41:436–42.
Geller TJ, Pan Y, Martin DS. Early neuroradiologic evidence of degeneration in Menkes’ disease. Pediatr Neurol. 1997;17:255–8.
Kodama H, Sato E, Yanagawa Y, et al. Biochemical indicator for evaluation of connective tissue abnormalities in Menke’s disease. J Pediatr. 2003;142:726–8.
Kaler SG, Holmes CS. Catecholamine metabolites affected by the copper-dependent enzyme dopamine-beta-hydroxylase provide sensitive biomarkers for early diagnosis of Menkes disease and viral-mediated ATP7A gene therapy. Adv Pharmacol. 2013;68:223–33.
Yokoyama A, Ohno K, Hirano A, et al. Cerebellar expression of copper chaperone for superoxide, cytosolic cu/zn-superoxide dismutase, 4-hydroxy-2-nonenal, acrolein and heat shock protein 32 in patients with Menkes kinky hair disease: immunohistochemical study. Yonago Acta Med. 2014;57:23–35.
Smith VV, Anderson G, Malone M. Light microscopic examination of scalp hair samples as an aid in the diagnosis of pediatric disorders: retrospective review of more than 300 cases from a single Centre. J Clin Pathol. 2005;58:1294–8.
Rudnicka L, Olszewska M, Waśkiel A, Rakowska A. Trichoscopy in hair shaft disorders. Dermatol Clin. 2018;36:421–30.
Kim OH, Suh JH. Intracranial and extracranial MR angiography in Menkes disease. Pediatr Radiol. 1997;27:782–4.
Rangarh P, Kohl N. Neuroimaging findings in Menkes disease: a rare neurodegenerative disorder. BMJ Case Rep. 2018;22:2018.
Seshadri R, Bindu PS, Gupta AK. Teaching neuroimages: Menkes kinky hair syndrome. Neurology. 2013;81:e12–3.
Kaler SG. Neurodevelopment and brain growth in classic Menkes disease is influenced by age and symptomatology at initiation of copper treatment. J Trace Elem Med Biol. 2014;28:427–30.
Kim B-E, Smith K, Petris MJ. A copper treatable Menkes disease mutation associated with defective trafficking of a functional MENKES copper ATPase. J Med Genetics. 2003;40:290–5.
Lem KE, Brinster LR, Tjurmina O, et al. Safety of intracerebroventricular copper histidine in adult rats. Mol Genet Metab. 2007;91:30–6.
Ogata R, Chong PF, Maeda K, et al. Long surviving classical Menkes disease treated with weekly intravenous copper therapy. J Trace Elem Med Biol. 2019;54:172–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Panteliadis, C.P., Hagel, C. (2022). Menkes Syndrome (Kinky Hair Disease; Trichothiodystrophy). In: Panteliadis, C.P., Benjamin, R., Hagel, C. (eds) Neurocutaneous Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-87893-1_43
Download citation
DOI: https://doi.org/10.1007/978-3-030-87893-1_43
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-87892-4
Online ISBN: 978-3-030-87893-1
eBook Packages: MedicineMedicine (R0)